Popular diabetes drugs may mess up colonoscopy prep, new study warns
NCT ID NCT07127354
First seen Jan 05, 2026 · Last updated May 25, 2026 · Updated 17 times
Summary
This study looks at how GLP-1 and GIP agonists (medicines for diabetes and weight loss) affect bowel preparation quality in people getting a colonoscopy. Researchers will compare what happens when patients either skip or take their usual dose before the procedure. The goal is to find out if these drugs make bowel prep less effective and if stopping them for one dose is safer.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLP-1 are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Cleveland Clinic
RECRUITINGCleveland, Florida, 44195, United States
-
Cleveland Clinic
RECRUITINGCleveland, Florida, 44195, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Cleveland Clinic Weston
RECRUITINGWeston, Florida, 33331, United States
Contact Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.